Potential clinical application of anti-Müllerian hormone testing in radioiodine treatment of thyroid carcinoma.

导出 OA

翻译打印收藏纠错

作者： Barbora,Havlínová ^[1] ; Ilona,Součková ^[2] ; Kateřina,Kopřivová ^[2] ; Jiří,Doležal ^[3]

作者单位： The 4th Department of Internal Medicine - Hematology, Faculty of Medicine in Hradec Králové, University Hospital Hradec Králové and Charles University, Sokolská 581, Hradec Králové, 50005, Czech Republic. barbora.havlinova@fnhk.cz. ^[1] Department of Clinical Immunology and Allergology, Faculty of Medicine in Hradec Králové, University Hospital Hradec Králové and Charles University, Hradec Králové, Czech Republic. ^[2] Department of Nuclear Medicine, Faculty of Medicine in Hradec Králové, University Hospital Hradec Králové and Charles University, Hradec Králové, Czech Republic. ^[3]

关键词 Anti-Müllerian hormone Ovarian reserve Premature ovarian failure Radioiodine treatment of thyroid cancer

主题词人类(Humans);抗苗勒管激素(Anti-Mullerian Hormone);碘放射性同位素(Iodine Radioisotopes);女(雌)性(Female);甲状腺肿瘤(Thyroid Neoplasms);成年人(Adult);前瞻性研究(Prospective Studies)

DOI 10.1186/s13104-024-06802-y

PMID 38783369

发布时间 2024-06-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交